suppl_data.jpg (27.51 kB)

Figure S1 Performance of rapid diagnostic tests for hepatitis C virus infection in serum or plasma

figure

posted on 2021-07-06, 13:04 authored by Françoise Roudot-Thoraval, Stéphane Chevaliez, Christophe Hézode, Jean-Michel PawlotskyJean-Michel Pawlotsky, Richard Njouom

Receiver operating characteristic (ROC) curves for the 7 RDT including SD Bioline HCV (bio) in blue, OraQuick HCV Rapid Antibody Test (ora) in green, Multisure HCV Antibody Assay (multi) in grey, Anti-HCV Card (card) in purple, Hexagon HCV (hexa) in red, Toyo anti-HCV test (toyo) in yellow, and First Response HCV Card Test (first) in pink. The reference line is shown. Areas under the curve (AUC) varied from 0.9792 to 0.9947 with p=0.116.

Funding

This work was funded by the Agence Nationale de Recherche sur le SIDA et les Hépatites Virales (ARNS). S. C. has received a research grant from Gilead and has served as an advisor and/or speaker for Abbott, Cepheid, and Hologic. C. H. has served as a speaker for Abbott. J.M.P. have received research grants from Roche and Gilead and have served as advisors for Abbvie, Gilead, GSK, Merck, Regulus and Siemens Healthcare. For the remaining authors, there are no conflicts of interest.

History

Usage metrics

Read the peer-reviewed publication

Performance of rapid diagnostic tests for hepatitis C virus infection in serum or plasma

Future Microbiology

Categories

Keywords

Hepatitis C rapid diagnostic test screening HCV antibodies low- and middle-income countries Infectious Agents Virology Infectious Diseases Medical Virology

Licence

CC BY-NC-ND 4.0

Exports